Scientists test 'Rebooted' immune cells to fight crippling autoimmune diseases
NCT ID NCT07473154
Summary
This early-stage study is testing an experimental treatment called QEL-005 in adults with two severe autoimmune conditions: difficult-to-treat rheumatoid arthritis and a serious form of systemic sclerosis. The treatment involves taking a patient's own immune cells, modifying them in a lab to potentially better control the disease, and infusing them back. The main goals are to see if this personalized cell therapy is safe and if it shows any early signs of reducing disease activity or improving symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS (SSC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Guy's & St Thomas NHS Foundation Trust
London, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Leeds Teaching Hospitals NHS Trust
Leeds, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Newcastle Upon Tyne NHS Foundation Trust
Newcastle, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Royal Free London NHS Foundation Trust
London, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Oxford - The Kennedy Institute
Oxford, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.